LIVN
LivaNova PLC
Electromedical & Electrotherapeutic Apparatus- 売上
- $1.4bn
- 時価総額
- $4.5bn
株価 $82.09 · 100株 8,209円
心肺および神経調節の医療機器と消耗品を世界中の医療機関に販売し収益を得る
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $1.2bn | $1.3bn | $1.4bn |
| 成長率 | — | 8.7% | 10.7% |
| 総利益 | $756m | $853m | $940m |
| 総利益率 | 65.5% | 68.1% | 67.7% |
| 販管費 | $503m | $509m | $549m |
| 販管費率 | 43.6% | 40.6% | 39.5% |
| 営利 | ▲$69m | $129m | $199m |
| 営利率 | ▲5.9% | 10.3% | 14.4% |
| 純利益 | $18m | $63m | ▲$242m |
| PBR | 3.5 | 3.4 | 3.7 |
| PSR | 3.9 | 3.6 | 3.2 |
| PGPR | 5.9 | 5.3 | 4.8 |
| PER | 256 | 71 | — |
| ﾈｯﾄｷｬｯｼｭ | ▲$320m | ▲$198m | $259m |
| EV/EBITDA | 284.9 | 21.8 | 14.8 |
| Rule of 40 | — | 19% | 25% |
| セールス効率 | — | 1,580% | 216% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）